Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
‘President of peace’: Trump tapped for Nobel Prize...
Trump’s push for Putin-Zelenskyy talks hinges on Kremlin’s...
Israel eliminates Gaza terrorist who took part in...
White House rejects ‘blank checks’ for Ukraine, presses...
Justice Barrett teases new memoir in abrupt conference...
Schiff launches legal defense fund in response to...
Gabbard removes clearances from 37 officials at Trump’s...
Russia launches largest attack on Ukraine this month...
Trump slams mail-in ballots as corrupt, but may...
I made memes for the White House. Here’s...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Business

DOJ sues Walgreens, alleging it ‘knowingly’ filled millions of invalid prescriptions

by admin January 19, 2025
January 19, 2025
DOJ sues Walgreens, alleging it ‘knowingly’ filled millions of invalid prescriptions

The Department of Justice said Friday that it sued pharmacy giant Walgreens over allegedly dispensing millions of unlawful prescriptions.

The DOJ said that Walgreens from August 2012 until the present “knowingly” filled those prescriptions, which “lacked a legitimate medical purpose, were not valid, and/or were not issued in the usual course of professional practice.” 

“This lawsuit seeks to hold Walgreens accountable for the many years that it failed to meet its obligations when dispensing dangerous opioids and other drugs,” said Principal Deputy Assistant Attorney General Brian Boynton, head of the DOJ’s Civil Division.

Boynton said that Walgreens pharmacists filled millions of prescriptions with “clear red flags that indicated the prescriptions were highly likely to be unlawful.”

The company “systematically pressured its pharmacists to fill prescriptions, including controlled substance prescriptions, without taking the time needed to confirm their validity,” Boynton said. “These practices allowed millions of opioid pills and other controlled substances to flow illegally out of Walgreens stores.”

Some Walgreens patients died of overdose deaths shortly after getting invalid prescriptions filled at Walgreens, the DOJ alleges.

The 300-page lawsuit was filed Thursday in U.S. District Court in Chicago.

Walgreens in a statement said, “We are asking the court to clarify the responsibilities of pharmacies and pharmacists and to protect against the government’s attempt to enforce arbitrary ‘rules’ that do not appear in any law or regulation and never went through any official rulemaking process.”

“We will not stand by and allow the government to put our pharmacists in a no-win situation, trying to comply with ‘rules’ that simply do not exist,” Walgreens said.

“Walgreens stands behind our pharmacists, dedicated healthcare professionals who live in the communities they serve, filling legitimate prescriptions for FDA-approved medications written by DEA-licensed prescribers in accordance with all applicable laws and regulations.”

The suit alleges that although Walgreens issued written policies that reflected its understanding of legal obligations, the company took other actions which it knew prevented its pharmacists from complying with them.

“Walgreens prioritized profits over safety and compliance by implementing policies and practices that required pharmacists to fill prescriptions quickly and left pharmacists without enough time or resources to exercise their corresponding responsibility,” the suit said.

“One such metric was ‘Verify By Promise Time’ (VBPT), which expected a pharmacist to fill a prescription within 15 minutes for a ‘waiter’ (a customer waiting in the pharmacy store for the prescription),” the suit alleges.

“Walgreens also tracked pharmacists that dispensed a low rate of controlled substances through its ‘Non-dispensing Pharmacist Report,’” the suit said.

“Walgreens created this metric in part because it believed pharmacists who refused to fill controlled-substance prescriptions compromised Walgreens’s customer service.”

This post appeared first on NBC NEWS

previous post
Obama wishes wife Michelle happy birthday as she stays away from key public events
next post
Tech 5: Trump to Prioritize Crypto, Biden Blocks AI Chip Exports

You may also like

Google loses antitrust case over search

August 7, 2024

E.l.f. Beauty to acquire Hailey Bieber skin care...

May 30, 2025

Klarna, nearing IPO, plucks lucrative Walmart fintech partnership...

March 19, 2025

Musk says time commitment to DOGE will ‘drop...

April 23, 2025

Flagging sales and Elon Musk’s political activities are...

March 17, 2025

East and Gulf coast ports shut down as...

October 3, 2024

Some Juul users are receiving thousands of dollars...

October 23, 2024

Babies R Us is back: Here’s why Kohl’s...

August 2, 2024

GM lays off more than 1,000 salaried software...

August 22, 2024

TGI Fridays operator files for Chapter 11 bankruptcy...

November 5, 2024

Recent Posts

  • ‘President of peace’: Trump tapped for Nobel Prize amid talks to end Russia-Ukraine war
  • Trump’s push for Putin-Zelenskyy talks hinges on Kremlin’s conditions
  • Israel eliminates Gaza terrorist who took part in October attack on kibbutz, took Yarden Bibas hostage
  • White House rejects ‘blank checks’ for Ukraine, presses NATO to shoulder costs
  • Justice Barrett teases new memoir in abrupt conference exit

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (881)
    • Investing (2,793)
    • Politics (3,430)
    • Stock (4)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 Sightful Invest. All Rights Reserved.